Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching.
Previous experiments have demonstrated that the rat dorsomedial striatum is one brain area that plays a crucial role in learning when conditions require a shift in strategies. Further evidence indicates that muscarinic cholinergic receptors in this brain area support adaptations in behavioral responses. Unknown is whether specific muscarinic receptor subtypes in the dorsomedial striatum contribute to a flexible shift in response patterns. The present experiments investigated whether blockade of M1-type and/or M4-type cholinergic receptors in the dorsomedial striatum underlie place reversal learning. Experiment 1 investigated the effects of the M1-type muscarinic cholinergic antagonist, muscarinic-toxin 7 (MT-7) infused into the dorsomedial striatum in place acquisition and reversal learning. Experiment 2 investigated the effects of the M4-type muscarinic cholinergic antagonist, muscarinic-toxin 3 (MT-3) injected into the dorsomedial striatum in place acquisition and reversal learning. All testing occurred in a modified cross-maze across two consecutive sessions. Bilateral injections of MT-7 into the dorsomedial striatum at 1 or 2 microg, but not 0.05 microg impaired place reversal learning. Analysis of the errors revealed that MT-7 at 1 and 2 microg significantly increased regressive errors, but not perseverative errors. An injection of MT-7 2 microg into the dorsomedial striatum prior to place acquisition did not affect learning. Experiment 2 revealed that dorsomedial striatal injections of MT-3 (0.05, 1 or 2 microg) did not affect place acquisition or reversal learning. The findings suggest that activation of M1-type muscarinic cholinergic receptors in the dorsomedial striatum, but not M4-type muscarinic cholinergic receptors facilitate the flexible shifting of response patterns by maintaining or learning a new choice pattern once selected.
McCool
Martha F
MF
Department of Psychology, Center for Cognitive Medicine, Laboratory of Integrative Neuroscience, University of Illinois at Chicago, Chicago, IL 60607, USA.
Patel
Sima
S
Talati
Ravi
R
Ragozzino
Michael E
ME
D000818:Animals; D001288:Attention / Q000187:drug effects; D001479:Basal Ganglia / Q000187:drug effects; D003071:Cognition / Q000502:physiology*; D003342:Corpus Striatum / Q000378:metabolism*; D004193:Discrimination Learning / Q000187:drug effects / Q000502:physiology*; D004334:Drug Administration Schedule; D004546:Elapid Venoms / Q000008:administration & dosage / Q000494:pharmacology; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D010455:Peptides / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D020318:Rats, Long-Evans; D043643:Receptor, Muscarinic M1 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D043588:Receptor, Muscarinic M4 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011950:Receptors, Cholinergic / Q000187:drug effects / Q000378:metabolism*
D004546:Elapid Venoms; D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; D043643:Receptor, Muscarinic M1; D043588:Receptor, Muscarinic M4; D011950:Receptors, Cholinergic; C089528:muscarinic toxin 3; C419876:muscarinic toxin 7
Brain Res. 1996 Sep 23;734(1-2):323-6
8896841
J Comp Neurol. 1992 Feb 15;316(3):314-47
1577988
Behav Neurosci. 1997 Oct;111(5):883-91
9383511
Neuroreport. 1998 May 11;9(7):1407-11
9631438
Pharmacol Rev. 1998 Jun;50(2):279-90
9647869
Neurobiol Learn Mem. 1998 Jul-Sep;70(1-2):119-36
9753592
Psychopharmacology (Berl). 1999 Mar;143(1):47-53
10227079
Neurobiol Learn Mem. 2005 Mar;83(2):125-33
15721796
Exp Brain Res. 1991;84(3):672-5
1864338
Am Rev Respir Dis. 1987 Mar;135(3):719-24
3826897
J Neurosci. 1992 Sep;12(9):3591-600
1527598
J Neurosci. 1993 Oct;13(10):4293-300
8410188
J Neurosci. 1990 Feb;10(2):508-19
2303856
Behav Brain Res. 1990 Mar 26;37(3):281-92
2340102
Proc Natl Acad Sci U S A. 1990 Sep;87(18):7050-4
2402490
J Neurosci. 1994 May;14(5 Pt 2):3351-63
8182478
J Neurosci. 1994 Jun;14(6):3969-84
8207500
FEBS Lett. 1994 Sep 19;352(1):91-4
7925952
J Neurophysiol. 1995 Mar;73(3):1234-52
7608768
Curr Opin Neurobiol. 1995 Dec;5(6):733-41
8805417
Neurobiol Learn Mem. 2005 Sep;84(2):93-101
15950501
Psychopharmacology (Berl). 2005 Sep;181(2):253-9
15846482
Nat Neurosci. 2006 Jun;9(6):832-42
16699510
J Neurosci. 2006 May 31;26(22):6004-10
16738243
Neurochem Res. 2006 Apr;31(4):555-61
16758365
Neuroscience. 2006 Dec13;143(3):671-8
17000053
Behav Brain Res. 2007 Feb 27;177(2):227-31
17182118
Exp Brain Res. 1999 Oct;128(4):531-4
10541747
Biochem Biophys Res Commun. 2000 May 10;271(2):435-9
10799315
Biochimie. 2000 Sep-Oct;82(9-10):793-806
11086210
Brain Res. 2001 Mar 9;894(1):12-20
11245810
Neuroscience. 2001;103(4):1017-24
11301208
Behav Neurosci. 2001 Jun;115(3):589-601
11439448
J Neurosci. 2001 Aug 1;21(15):5730-9
11466445
Behav Neurosci. 2002 Feb;116(1):105-15
11898801
Brain Res. 2002 Oct 25;953(1-2):205-14
12384254
Eur J Neurosci. 2002 Dec;16(11):2017-26
12473069
Pharmacol Biochem Behav. 2003 Jan;74(2):411-5
12479962
J Neurosci. 2003 Apr 1;23(7):3001-5
12684487
J Neurosci. 2003 Sep 24;23(25):8771-80
14507977
Behav Neurosci. 2003 Oct;117(5):1054-65
14570554
Learn Mem. 2004 Jan-Feb;11(1):70-7
14747519
Behav Brain Res. 2004 Sep 23;154(1):245-53
15302131
Behav Neurosci. 2004 Aug;118(4):730-9
15301600
Neurobiol Learn Mem. 2004 Sep;82(2):81-9
15341793
J Comp Physiol Psychol. 1967 Apr;63(2):184-90
4963561
Percept Mot Skills. 1969 Oct;29(2):550
5361725
Physiol Behav. 1977 Feb;18(2):237-44
559316
Proc Natl Acad Sci U S A. 1984 Aug;81(15):4998-5001
6589643
Exp Brain Res. 1997 Oct;116(3):456-66
9372294